Alhambra Investment Management LLC
Source: SEC Form 13F · as of Mar 2026Alhambra Investment Management LLC holds 13 biotech & pharma companies tracked by BioSniper, totaling $10.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$10.1M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 8,646 | $2.1M |
| AMGNAMGEN INC | 4,314 | $1.5M |
| MRKMerck & Co., Inc. | 10,534 | $1.3M |
| LLYELI LILLY & Co | 1,126 | $1.0M |
| NVSNovartis AG | 5,232 | $799K |
| ABBVAbbVie Inc. | 3,209 | $698K |
| AZNASTRAZENECA PLC | 2,784 | $549K |
| GEHCGE HealthCare Technologies Inc. | 6,168 | $439K |
| BMYBRISTOL MYERS SQUIBB CO | 7,068 | $429K |
| INCYIncyte Corp. | 3,882 | $365K |
| ABTABBOTT LABORATORIES | 3,454 | $355K |
| GILDGILEAD SCIENCES, INC. | 1,858 | $259K |
| PFEPFIZER INC | 9,165 | $257K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.